Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Ut Kei Lou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-6287-4393; OpenAlex author ID A5068860383. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 3 papers · 2021: none · 2022: 1 paper

Papers 4

  1. CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein. First author DOI 10.1186/s12943-021-01481-w↗
  2. CircFOXK2 Promotes Tumor Growth and Metastasis of Pancreatic Ductal Adenocarcinoma via Complexing with RNA Binding Proteins and Sponging MiR-942 First author DOI 10.1016/j.pan.2020.07.369↗
  3. A simple and rapid colorimetric detection of serum lncRNA biomarkers for diagnosis of pancreatic cancer. Co-author DOI 10.1039/c9ra07858d↗
  4. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942. First author DOI 10.1158/0008-5472.can-19-3268↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chi Hin Wong · 3 shared papers, 2020–2022 · strength 0.48
  2. Yangchao Chen · 3 shared papers, 2020–2022 · strength 0.48
  3. Stephen Lam Chan · 2 shared papers, 2020–2022 · strength 0.29
  4. Yuanfeng Chen · 1 shared paper, 2020 · strength 0.13
  5. Chi Chun Wong · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.